DELIVERY ORDER
Active75N98026F00001
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH OLAO
$339.5K
obligated · signed 1 week ago
GLP REPEAT DOSE TOXICOLOGY STUDY FOR A LIVE-ATTENUATED RESPIRATORY VIRUS VACCINE.
Performance timeline
Start
Sep 28, 2026
End
Mar 27, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Mar 27, 2027
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
Contract 75N98026F00001
UEI
MBT9RXJJ7428
Parent Company
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
Capabilities & Certifications
Headquarters Location
Congressional District: 01
Current Obligation
$339,534
Base + Exercised Options
$339,534
Total Ceiling Value
$339,534
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH OLAO
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Contract Vehicle
75N93021D00031
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.